Results
1 -
10 of
15Development of novel antibacterial drugs to combat multiple resistant organisms, Langenbeck's Archives of Surgery Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones, World Journal of Microbiology and Biotechnology Neue Antibiotika auf dem Markt und in Entwicklung, Der Internist Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin, Annals of Clinical Microbiology and Antimicrobials Bacterial Topoisomerase Inhibitors: Quinolones and Beyond, Antimicrobials Nemonoxacin: First Global Approval, Drugs Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006u20132010, European Journal of Clinical Microbiology & Infectious Diseases Management of pneumonia, Clinical Management of Bacterial Pneumonia Differences between methicillin-resistant Staphylococcus aureus bacteremic isolates harboring type IV and type V staphylococcal cassette chromosome mec genes based on prior patient healthcare exposure, European Journal of Clinical Microbiology & Infectious Diseases